Cambridge Heartwear secured a contract with the U.K. National Health Service for its wearable, medical-grade ECG recorder that connects with the user’s smartphone to diagnose abnormal heart rhythms. The £184 million tender, worth about $192 million U.S., will supply the NHS with HeartSense recorders across its primary and secondary care offices, as well as civil […]
MassDevice Cardiovascular Hub
MassDevice's Cardiovascular Hub is your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Check out our latest feature:
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ MassDevice’s Cardio Device Companies Special Report
+ 12 things you need to know about the transcatheter heart valves market
+ The top cardiovascular tech stories out of TCT 2025
+ First Look: Boston Scientific’s next-gen Faraflex PFA and mapping catheter
+ How Abbott dialed in the waveform for its Volt PFA system
+ The top 10 cardiac device stories of 2024
+ The latest AI-powered cardiology devices you need to know
Latest Cardiology News
Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
The Teleflex (NYSE: TFX) Freesolve RMS (resorbable magnesium scaffold) has won FDA Breakthrough Device designation for percutaneous coronary intervention (PCI). “Freesolve RMS has the potential to provide physicians with an additional treatment option, by reducing the need for permanent implants and potentially offering an alternative to drug-coated balloons in cases where temporary scaffolding is required […]
J&J, Medtronic present pulsed field ablation data from global real-world use
Johnson & Johnson and Medtronic have both put forward clinical data supporting their dueling pulsed field ablation platforms, highlighting low rates of complications in international real-world use. The studies were presented at the annual scientific meeting of the Asia Pacific Heart Rhythm Society, being held in Busan, South Korea. Johnson & Johnson MedTech (NYSE: JNJ) […]
Edwards wins FDA approval for Pascal Precision in tricuspid valve repair
Edwards Lifesciences (NYSE: EW) obtained FDA approval for its minimally invasive procedure to help repair a leaky tricuspid heart valve. The agency’s green light in severe tricuspid regurgitation adds the clip-based Pascal Precision system alongside Edwards’ Evoque implant for replacing the valve entirely. According to the company, the latest approval now makes it the only […]
J&J launches faster Shockwave coronary catheter in the US
Johnson & Johnson (NYSE: JNJ) is launching the latest version of its intravascular lithotripsy catheter for cracking calcium within the coronary arteries, which the company said it designed to cut treatment times in half. The Shockwave C2 Aero Fly catheter delivers ultrasonic energy at double the speed of its previous version and with less time […]
Haemonetics wins FDA approval of PerQseal Elite vascular closure system
Haemonetics (NYSE: HAE) has received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures, following the company’s $116.4 million acquisition of Vivasure Medical in January 2026. The FDA approval, announced yesterday, expands Boston-based Haemonetics’ U.S. portfolio of large-bore closure devices for structural heart and endovascular procedures. The PerQSeal Elite system is […]
Medtronic nets CE mark for Vitalis family of conduction system pacemakers
Medtronic (NYSE: MDT) has claimed a CE mark for its latest portfolio of pacemakers designed for conduction system pacing, which taps into the heart’s natural electrical pathways. The European approval for the Vitalis implant family includes the ReSyncra CSP, Restoria CSP, Refina CSP, Effectra and Confirma pacemakers designed to address a wide variety of patients. […]
E2’s pulmonary embolism platform claims two FDA clearances
Endovascular Engineering (E2) has received a pair of FDA clearances for its pulmonary embolism treatment platform, spanning its dual-action thrombectomy system and hardware that returns filtered blood to the patient. The Hēlo system combines continuous vacuum aspiration with physical agitation to help break up the blood clot. Its catheter starts with a lower-profile, 15-French design […]
FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
Edwards Lifesciences (NYSE: EW) has warned healthcare providers to stop using certain delivery catheters for its transcatheter mitral valve replacement system, following reports of their balloons bursting during the procedure. The FDA issued its own alert this week, saying three incidents as of earlier this month have resulted in one death and one serious injury […]
Former Medtronic RDN leader joins Teleflex
Teleflex (NYSE: TFX) has hired Jason Fontana as president and general manager of its interventional cardiology business, the former Medtronic executive said today. Fontana spent more than two decades at the world’s largest medical device company, rising to the position of VP and general manager of the renal denervation (RDN) group that won FDA premarket […]
GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark
GE HealthCare (Nasdaq: GEHC) has claimed a European approval for a relatively compact, self-shielded cyclotron designed for the local production of the rapidly decaying isotopes used in PET imaging tracers. The CE Mark for the MINItrace Magni enables the in-house supply of fluorine-18 — the molecule used to power GE HealthCare’s Flyrcado, Cerianna and Vizamyl […]
